Trials / Terminated
TerminatedNCT00383266
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study of an investigational agent, pemetrexed, in combination with a standard chemotherapy drug, carboplatin, for treatment of patients with metastatic esophageal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pemetrexed | |
| DRUG | Carboplatin |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2009-11-01
- Completion
- 2010-06-01
- First posted
- 2006-10-03
- Last updated
- 2016-01-11
- Results posted
- 2016-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00383266. Inclusion in this directory is not an endorsement.